← Back to Search

Behavioural Intervention

Blood Flow Restriction Exercise for Multiple Sclerosis (BFR-MS Trial)

N/A
Waitlist Available
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline (week 0) and post test (week 9)
Awards & highlights

BFR-MS Trial Summary

This trial is testing whether 8 weeks of physical therapy exercises using BFR may help improve walking in people with MS who have moderate-to-severe walking problems.

Eligible Conditions
  • Multiple Sclerosis

BFR-MS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline (week 0) and post test (week 9)
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline (week 0) and post test (week 9) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in ankle plantarflexion muscle strength
Change in hip abduction muscle strength
Change in knee extension muscle strength
Secondary outcome measures
Change in 12-Item MS Walking Scale
Change in 30-second sit-to-stand completions
Change in Berg Balance Scale
+5 more

BFR-MS Trial Design

1Treatment groups
Experimental Treatment
Group I: Blood Flow Restriction ExerciseExperimental Treatment1 Intervention
Participant will participate in a supervised low load blood flow restriction exercise program twice a week for 8 weeks.

Find a Location

Who is running the clinical trial?

Consortium of Multiple Sclerosis CentersOTHER
8 Previous Clinical Trials
50,144 Total Patients Enrolled
8 Trials studying Multiple Sclerosis
50,144 Patients Enrolled for Multiple Sclerosis
University of Colorado, DenverLead Sponsor
1,735 Previous Clinical Trials
2,149,156 Total Patients Enrolled
20 Trials studying Multiple Sclerosis
2,752 Patients Enrolled for Multiple Sclerosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025